Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.510
-0.010 (-0.66%)
At close: Aug 28, 2026, 4:00 PM EDT
1.470
-0.040 (-2.65%)
After-hours: Aug 28, 2026, 4:10 PM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $5.51 million as of August 28, 2026. Its market cap has decreased by -68.93% in one year.
Market Cap
5.51M
Enterprise Value
3.35M
1-Year Change
-68.93%
Ranking
Category
Stock Price
$1.51
ChartMarket Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $5.51M, a decrease of -96.67%. That is a compound annual growth rate of -26.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 5.51M | -32.29% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.27M |
| Enveric Biosciences | 6.13M |
| Processa Pharmaceuticals | 5.75M |
| Liminatus Pharma | 5.68M |
| Kairos Pharma | 5.62M |
| PharmaCyte Biotech | 5.53M |
| Cadrenal Therapeutics | 5.49M |
| Cardio Diagnostics Holdings | 5.45M |